Statistics for Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report
Total visits
| views | |
|---|---|
| Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report | 0 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |